Your browser doesn't support javascript.
loading
G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial.
Stopka, Tomás; Minarík, Lubomír; Dusilková, Nina; Pesta, Michal; Kulvait, Vojtech; Spacek, Martin; Zemanová, Zuzana; Kalousová, Marta; Jonásová, Anna.
Afiliación
  • Stopka T; Haematology Clinic, General Faculty Hospital, Prague, Czech Republic. tstopka@lf1.cuni.cz.
  • Minarík L; BIOCEV, 1st Medical Faculty, Charles University, Vestec, Czech Republic. tstopka@lf1.cuni.cz.
  • Dusilková N; Haematology Clinic, General Faculty Hospital, Prague, Czech Republic.
  • Pesta M; BIOCEV, 1st Medical Faculty, Charles University, Vestec, Czech Republic.
  • Kulvait V; Haematology Clinic, General Faculty Hospital, Prague, Czech Republic.
  • Spacek M; BIOCEV, 1st Medical Faculty, Charles University, Vestec, Czech Republic.
  • Zemanová Z; Pathophysiology, 1st Medical Faculty, Charles University, Prague, Czech Republic.
  • Kalousová M; Faculty of Mathematics & Physics, Charles University, Prague, Czech Republic.
  • Jonásová A; BIOCEV, 1st Medical Faculty, Charles University, Vestec, Czech Republic.
Blood Cancer J ; 12(7): 105, 2022 07 07.
Article en En | MEDLINE | ID: mdl-35798720
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: República Checa
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: República Checa